Bupropion Sustained released versus Placebo for seasonal affective Disorder

Journal Title: Archives of Depression and Anxiety - Year 2017, Vol 3, Issue 1

Abstract

Background: The majority of seasonal affective disorder (SAD) studies have evaluated the use of light or selective serotonin reuptake inhibitors (SSRI). The purpose of the present study was to evaluate bupropion sustained-released (SR), a non-SSRI antidepressant, for the treatment of SAD. Method: Forty-one adults meeting DSM IV criteria for SAD were recruited into a six-week, randomized, double-blind, placebo-controlled trial. Participants started on bupropion SR 150 mg QD (or equivalent placebo pills) and titrated up to 200 mg BID if tolerated by week 4. Participants were evaluated weekly with SIGH-SAD and self-reported Kellner Symptom Questionnaire (SQ). Mixed effects growth models and receiver operating characteristic (ROC) analyses were used to compare treatments. Results: Analysis was done on the 36 participants who completed at least 2 weeks of treatment, as per protocol. Thirty-four participants completed the entire protocol; two participants receiving placebo dropped out during weeks 3 and 5. Sixteen participants (7 male, 9 female, 46.5 + 9.6 years, mean+SD) received bupropion SR and 20 participants (8 males, 12 females, 48.2+8.8 years) received placebo. Participants receiving bupropion SR had a more rapid reduction in atypical SIGH-SAD depressive symptoms and lower depression scores across time on the SQ. ROC analyses revealed that positive effects of bupropion SR on total SIGH-SAD scores were more evident in males than females. Bupropion SR was well tolerated. Conclusion: Bupropion SR may be beneficial for the treatment of SAD, but larger randomized placebo-controlled studies are warranted.

Authors and Affiliations

Teicher Martin H

Keywords

Related Articles

Hypochondriacal delusion in an elderly man with good response to electroconvulsive therapy but complicated with febrile reaction

In this case report, we present an elderly gentleman with prominent somatic delusions associated with depressive features. He was diagnosed to have severe depressive episode with mood congruent psychotic symptoms and was...

Maternal health problems such as depression and anxiety and parent-child interaction

Background: The emotional climate between mothers and their children is known to be a significant indicator for the development of childhood psychopathology. One index that allows measuring family-emotional climate is th...

Clinical pharmacology of anxiolytics

It is increasingly difficult to define what an anxiolytic is, since anxiety is multiple although many symptoms are common. On the other hand the most used drugs in different forms of anxiety were first used as antidepres...

Is genetic counseling for cancer predisposition always associated with distress? A pre-post intervention study to assess probands’ pre-and post-counseling level of anxiety and satisfaction

Genetic counseling for cancer predisposition is associated with a potentially underestimated emotional impact. The Genetic Counseling Service of the Institute of Oncology of Southern Switzerland evaluated the degree of a...

Psychoeducation of bipolar disorder patients and their relatives

Until recently, there was the belief that people with bipolar disorder were not fit to be treated with psychological therapies, which has been widely denied in recent years. While it is true that the effects of therapy a...

Download PDF file
  • EP ID EP334354
  • DOI 10.17352/2455-5460.000016
  • Views 70
  • Downloads 0

How To Cite

Teicher Martin H (2017). Bupropion Sustained released versus Placebo for seasonal affective Disorder. Archives of Depression and Anxiety, 3(1), 9-13. https://europub.co.uk/articles/-A-334354